AIM ImmunoTech Inc. 8-KCurrent Reports (8-K / ad hoc)

Changes / Accountants

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Form of Exchange Agreement. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). Field: Page; Sequence: 2 Field: /Page SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 14, 2026 AIM ImmunoTech Inc. By: /s/ Thomas K. Equels Thomas K. Equels Chief Executive Officer Field: Page; Sequence: 3; Options: Last Field: /Page Field: Set; Name: xdx; ID: xdx_08B_extensions eJxFjd0KgkAQhZ/Adxj2WkqthLxMTCKLkIhuFx1jSXdkdvt7pN6yTYmGgWHmnG+OEL7Iaa1aZDivygKO2PWttAglNsioK3SOdLNNwM0SL8pYltoO6w9MyTHomHiyqNx9cN6VwTqBYDkN59MohjBKghkcdsL76inpRtWorZItSF3DgalnhVbya/xwlE/S1L2GpBOyUaQTCCfBKL8hCsII9nSXD+KrgaJIhecP5Ymc6dY7V/a0qL8kZC12Ls6M9L+9D8+hSmI=